Success Story: Fast-Track NIW Success! Indian Research Associate Scientist Approved with Our Expert Support and Premium Processing Service

Posted by wegreened on August 8, 2025 in NIW, Chemistry (Organic Chemistry, Biochemistry, Biochemical Engineering, Electrochemical Engineering, Physical Chemistry, Macromolecular Engineering, Polymer Chemistry, Chemical Engineering)

Client’s Testimonial:

“Thank you very much for all your help through the NIW process. An approval without an RFE seems to be a rarity these days, and I was happy to receive the decision well before the 45-day deadlines. This talks to the strength and clarity in the petition. I am so excited to receive the approval and really appreciate your expert advice and assistance with the filing.”

On April 4^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Associate Scientist in the Field of Clinical Biochemistry (Approval Notice).

General Field: Clinical Biochemistry

Position at the Time of Case Filing: Research Associate Scientist

Country of Origin: India

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: April 4^th, 2025

Processing Time: 1 month, 14 days (Premium Processing Requested)

Case Summary:

We are proud to share the successful I-140 NIW approval of a Ph.D. holder in biochemistry whose cutting-edge research is significantly advancing the diagnosis and treatment of genetic metabolic disorders, with a focus on enhancing the quality of life for affected children.

Currently employed as a research associate scientist at a leading U.S. medical institution, the client’s proposed endeavor centers on developing innovative biochemical enzyme assays. These efforts aim to facilitate early diagnosis, precise disease monitoring, and effective treatment of rare inherited metabolic disorders.

To support his petition under the National Interest Waiver (NIW) category, we highlighted:

● An impressive publication record of 18 peer-reviewed journal articles and 7 conference abstracts, many first-authored and published in top-tier journals;

● Over 304 citations, including multiple papers ranked among the top 10–20% most cited in the field of biology and biochemistry for their respective years;

● A strong peer review portfolio with at least 14 completed reviews for prestigious journals in clinical biochemistry and related fields;

● Substantial research funding from the National Institutes of Health (NIH), underscoring the national importance and impact of his work.

His research has elucidated critical biochemical pathways and the development of mass spectrometry-based techniques for sensitive diagnosis and monitoring of inherited metabolic disorders. These contributions have been widely cited and form the foundation for ongoing advances in metabolic disorder diagnostics and therapeutics.

The strength of his credentials and the national significance of his research led to approval after 1 month and 14 days via premium processing. We congratulate him on this important achievement and anticipate his continued leadership in clinical biochemistry and genetic metabolic disorder research, driving forward innovations that benefit public health.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%